Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2026-02-19 @ 1:19 PM
Study NCT ID:
NCT00489658
Status:
TERMINATED
Last Update Posted:
2007-06-21
First Post:
2007-06-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda
Sponsor:
Epicentre
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Trypanosomiasis, African | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Human African trypanosomiasis | View |
| None | sleeping sickness | View |
| None | Trypanosoma brucei gambiense | View |
| None | combination | View |
| None | eflornithine | View |
| None | nifurtimox | View |
| None | Human African trypanosomiasis (sleeping sickness) due to Trypanosoma brucei gambiense … | View |